Janus Henderson Group’s First Tracks Biotherapeutics TRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding TRAX
Janus Henderson Group's TRAX Position: Q3 2026 in Review
Janus Henderson Group opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 1,095,631 shares worth $38.8M. The stake represents 0.02% of the portfolio and ranks #480 among its holdings.
174 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.
- Janus Henderson Group held 1,095,631 shares of First Tracks Biotherapeutics worth $38.8M as of Q3 2026.
- First Tracks Biotherapeutics was a new Janus Henderson Group position in Q3 2026.
- First Tracks Biotherapeutics made up 0.02% of Janus Henderson Group's portfolio in Q3 2026, its #480 holding.
- 174 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.
Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.